Although immunohistochemical staining of Tie1 in tumor samples is associated with poor patient survival in breast cancer [35], the availability of tissue samples from metastatic tumors varies depending on tumor location, tumor load and the clinical need to accept the complication risks and discomfort related to needle aspirations. Here, TIE1 is linked to breast cancer.